Related Experiment Video
Updated: Aug 24, 2026

Evaluation of Oxidative Stress in Biological Samples Using the Thiobarbituric Acid Reactive Substances Assay
Published on: May 12, 2020
Effects of statins on oxidative stress
M Ilker Yilmaz1, Y Baykal, M Kilic
1Department of Internal Medicine, Gülhane School of Medicine, Etlik-Ankara, Turkey.
Insights
Fluvastatin therapy improved antioxidant status in hypercholesterolemia (HC) patients by reducing oxidative stress and enhancing antioxidant enzymes. This suggests fluvastatin
Area of Science:
- Biochemistry
- Clinical Medicine
- Nutritional Science
Background:
- Hypercholesterolemia (HC) is linked to oxidative stress from free oxygen radicals and low antioxidant enzyme activity.
- Trace elements are crucial cofactors for antioxidant enzymes, but their combined role with the antioxidant system in HC patients is understudied.
Purpose of the Study:
- To investigate the antioxidative system and trace element status in hypercholesterolemic patients undergoing fluvastatin therapy.
- To evaluate the impact of fluvastatin on oxidative stress markers and antioxidant enzyme activities.
Main Methods:
- Measured erythrocyte malondialdehyde (MDA), copper zinc-superoxide dismutase (CuZn-SOD), and glutathione peroxidase (GSH-Px) activities.
- Assessed erythrocyte copper (Cu), iron (Fe), and zinc (Zn) levels in 35 HC patients and 27 controls.
- Analyzed plasma lipid levels and oxidative state before and after 3 months of fluvastatin treatment.
Main Results:
- HC patients exhibited higher MDA levels and lower CuZn-SOD and GSH-Px activities compared to controls.
- Erythrocyte iron levels were elevated, while copper and zinc levels were reduced in HC patients.
- Fluvastatin treatment led to significant improvements in the oxidative state.
Conclusions:
- Fluvastatin demonstrates notable antioxidant properties in hypercholesterolemic patients.
- These antioxidant effects may play a significant role in managing dyslipidemia through improved endothelial function.
Abstract:
Free oxygen radicals and insufficient antioxidant enzymes have been implicated in the pathogenesis of hypercholesterolemia (HC). Trace elements function as cofactors in antioxidant enzymes. Antioxidant system and trace elements were investigated in many different studies including HC, but these subjects have not been investigated as a whole in these patients. The aim of the present study was to investigate the antioxidative system and trace elements in hypercholesterolemic patients given fluvastatin therapy. We examined malondialdehyde (MDA), copper zinc-superoxide dismutase (CuZn-SOD), and glutathione peroxidase (GSH-Px) activities together with copper (Cu), iron (Fe), and zinc (Zn) levels in erythrocytes of 35 patients with HC and 27 healthy control subjects. It was found that in patients with HC, erythrocyte MDA was significantly higher than those of controls and erythrocyte CuZn-SOD and GSH-Px activities were significantly lower in patients with HC. Erythrocyte iron levels were significantly higher than those of controls, and erythrocyte copper and zinc levels were significantly lower in patients with HC. Plasma lipid levels and the oxidative state were analyzed in statin-treatment groups given fluvastatin therapy before and after a 3-mo treatment period. In conclusion, we found that fluvastatin has significant antioxidant properties and these effects might be very important in managing dyslipidemia by improving endothelial function.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Peroxisomes
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...